Net Margin - InnoCare Pharma Ltd (SSE:688428) - Alpha Spread

InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 11.33 CNY -2.16% Market Closed
Market Cap: 9.6B CNY
Have any thoughts about
InnoCare Pharma Ltd?
Write Note

Net Margin
InnoCare Pharma Ltd

-141.8%
Current
-9 617%
Average
-7.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-141.8%
=
Net Income
-886.6m
/
Revenue
625.4m

Net Margin Across Competitors

Country CN
Market Cap 9.6B CNY
Net Margin
-142%
Country US
Market Cap 341.7B USD
Net Margin
10%
Country US
Market Cap 181.2B USD
Net Margin
10%
Country US
Market Cap 127.2B USD
Net Margin
32%
Country US
Market Cap 120B USD
Net Margin
-5%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country US
Market Cap 104.6B USD
Net Margin
4%
Country AU
Market Cap 141.9B AUD
Net Margin
18%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country US
Market Cap 38.5B USD
Net Margin
-557%
Country US
Market Cap 35.1B USD
Net Margin
-3%

Profitability Report

View the profitability report to see the full profitability analysis for InnoCare Pharma Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-141.8%
=
Net Income
-886.6m
/
Revenue
625.4m
What is the Net Margin of InnoCare Pharma Ltd?

Based on InnoCare Pharma Ltd's most recent financial statements, the company has Net Margin of -141.8%.